CN109207469A - 一种高产维生素b12的突变菌株制备方法 - Google Patents
一种高产维生素b12的突变菌株制备方法 Download PDFInfo
- Publication number
- CN109207469A CN109207469A CN201811109813.9A CN201811109813A CN109207469A CN 109207469 A CN109207469 A CN 109207469A CN 201811109813 A CN201811109813 A CN 201811109813A CN 109207469 A CN109207469 A CN 109207469A
- Authority
- CN
- China
- Prior art keywords
- strain
- fermentation
- vitamin
- mutagenesis
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 title claims abstract description 36
- 229930003779 Vitamin B12 Natural products 0.000 title claims abstract description 35
- 239000011715 vitamin B12 Substances 0.000 title claims abstract description 35
- 235000019163 vitamin B12 Nutrition 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims abstract description 54
- 230000004151 fermentation Effects 0.000 claims abstract description 54
- 241000894006 Bacteria Species 0.000 claims abstract description 32
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 28
- 238000012216 screening Methods 0.000 claims abstract description 28
- 238000002703 mutagenesis Methods 0.000 claims abstract description 25
- 230000001580 bacterial effect Effects 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 239000000725 suspension Substances 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims abstract description 7
- 238000009655 industrial fermentation Methods 0.000 claims abstract description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 235000013379 molasses Nutrition 0.000 claims description 19
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 16
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 16
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 16
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 15
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 15
- 229910000388 diammonium phosphate Inorganic materials 0.000 claims description 14
- 239000001963 growth medium Substances 0.000 claims description 14
- 229940099596 manganese sulfate Drugs 0.000 claims description 13
- 235000007079 manganese sulphate Nutrition 0.000 claims description 13
- 239000011702 manganese sulphate Substances 0.000 claims description 13
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 13
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 13
- 229960001763 zinc sulfate Drugs 0.000 claims description 13
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 12
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 12
- 235000019838 diammonium phosphate Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- LJUQGASMPRMWIW-UHFFFAOYSA-N 5,6-dimethylbenzimidazole Chemical compound C1=C(C)C(C)=CC2=C1NC=N2 LJUQGASMPRMWIW-UHFFFAOYSA-N 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 9
- 241000335053 Beta vulgaris Species 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 9
- 239000002609 medium Substances 0.000 claims description 9
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims description 8
- 238000010899 nucleation Methods 0.000 claims description 8
- 239000006052 feed supplement Substances 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 229910052734 helium Inorganic materials 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- 231100000219 mutagenic Toxicity 0.000 claims description 4
- 230000003505 mutagenic effect Effects 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 238000011218 seed culture Methods 0.000 claims description 3
- 235000002639 sodium chloride Nutrition 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000005660 chlorination reaction Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- -1 phosphoric acid Hydrogen Chemical class 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 210000000232 gallbladder Anatomy 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 3
- 238000011017 operating method Methods 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 235000019743 Choline chloride Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- WUPRCGRRQUZFAB-DEGKJRJSSA-N corrin Chemical class N1C2CC\C1=C\C(CC/1)=N\C\1=C/C(CC\1)=N/C/1=C\C1=NC2CC1 WUPRCGRRQUZFAB-DEGKJRJSSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HNBDQABBWNOTRU-UHFFFAOYSA-N thalline Chemical compound C1=CC=[Tl]C=C1 HNBDQABBWNOTRU-UHFFFAOYSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 1
- 101150044802 B12 gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000186428 Propionibacterium freudenreichii Species 0.000 description 1
- 241000186334 Propionibacterium freudenreichii subsp. shermanii Species 0.000 description 1
- 241000168053 Pseudomonas denitrificans (nomen rejiciendum) Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- AGVAZMGAQJOSFJ-UHFFFAOYSA-M cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1h-corrin-21-id-3-yl]propanoylamino]propan-2 Chemical compound [Co+2].N#[C-].OCC1OC(N2C3=CC(C)=C(C)C=C3N=C2)C(O)C1OP(O)(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O AGVAZMGAQJOSFJ-UHFFFAOYSA-M 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/42—Cobalamins, i.e. vitamin B12, LLD factor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于生物工程中的菌种制备技术领域,涉及一株高产维生素B12成分的突变菌株及工业发酵技术,特别是一种高产维生素的突变菌株的生产培育方法;涉及的脱氮假单胞菌的具体诱变工艺步骤包括:出发菌悬液制备、诱变、菌落计数、菌株初筛和菌株复筛;其通过对原始菌株进行诱变后,再次通过常温常压等离子体(ARTP)诱变技术对一株具有典型诱变特征的菌株进行了诱变,最终获得遗传性质稳定、发酵水平较高的菌种;涉及的突变菌株TP‑121实现工业发酵生产维生素B12的方法包括如下步骤:种瓶制备、种子罐培养和发酵罐培养;其工艺原理可靠,操作步骤简单,技术条件成熟,菌种优质,维生素产量高,应用环境友好。
Description
技术领域:
本发明属于生物工程中的菌种制备技术领域,涉及一株高产维生素B12成分的突变菌株及工业发酵技术,特别是一种高产维生素的突变菌株的生产培育方法。
背景技术:
维生素B12,又称钴胺素,是一系列含有以钴原子为中心的咕啉核和以5,6-二甲基苯并咪唑为碱基的核苷酸且对人和动物具有生物活性的咕啉累有机化合物的总称;维生素B12的化学结构如图1所示;目前主要通过利用费氏丙酸杆菌(Propionibacteriumfreudenreichii)和谢氏丙酸杆菌(Propionibacterium shermanii)的厌氧发酵以及利用脱氮假单胞菌(Pseudomonas denitrificans)进行的好氧发酵实现VB12的工业生产。近几十年来,世界各国科研和生产工作者们为了提高维生素B12的发酵式生产水平进行了不懈努力;如中国专利CN102453690A公布了一种脱氮假单胞菌发酵生产维生素B12高产菌株的诱变方法,通过化学诱变和低能离子注入诱变筛选获得一株突变菌种,使得发酵单位提高8-12%;中国专利号为CN101538599A的发明专利公开了一种利用最适的甜菜碱初始添加量和最适的甜菜碱补料量提高脱氮假单胞菌发酵生产维生素B12的方法;中国专利号CN101748177的发明专利公布了一种通过调整培养基中的钾离子浓度优化脱氮假单胞菌的发酵生产工艺,并对合成培养基进行了系统优化使得发酵单位有所提高。尽管这些现有技术和研究新成果也已经达到了一定的技术水平,生产的维生素质量也很好,但是利用诱变、DNA重组技术或其他新工艺方法获得优良菌株,提高维生素B12基因在受体菌中的表达水平,进一步优化维生素B12的发酵和提取工艺以及保存条件,仍然是维生素B12在各行业领域进行广泛探讨和应用的重要任务。
发明内容:
本发明的目的在于克服现有技术存在的缺点,寻求设计提供一种高产维生素B12的突变菌株的工业发酵方法,将其制备的突变菌株应用于工业生产中制取维生素B12。
为了实现上述目的,本发明的工艺技术中所述的高产维生素B12的菌株为脱氮假单胞菌(Aspergillus niger)TP-121,是由脱氮假单胞菌TY-007通过常温常压等离子体(ARTP)诱变筛选获得的高产菌株,其菌株形态特征在于镜检菌丝较短,菌形排列一致,着色较深,摇瓶后期菌丝拉长产生膨大端;其中,脱氮假单胞菌TY-007是一株经紫外诱变筛选得到的高产维生素B12菌株,其发酵水平较原始菌提高了10.8%,该菌经液体培养后菌丝较长,易相互缠绕,致使发酵液粘稠,不利于发酵后期的传质和传氧,也不利于提取工段操作,将其作为出发菌种再次诱变;本菌种的最适生长温度为30℃,生长所需的pH范围为7.3-7.5;所述脱氮假单胞菌株TP-121所产维生素B12达到320-350ug/mL。
本发明涉及的脱氮假单胞菌的具体诱变工艺步骤如下:
(1)出发菌悬液制备:取两株出发菌株的新鲜斜面,用无菌水洗脱菌体,在有玻璃珠的试管振荡使菌体分散,离心收集菌体,以5%甘油重悬菌体,以血球计数板计数直至菌浓为107-108个/mL,制得出发菌悬液;
(2)诱变:开启常温常压等离子出发系统,以酒精棉擦拭操作室内外空间,并开启紫外灯灭菌30min,灭菌结束后取10μL菌悬液点于载片的粗糙面,并在无菌条件下将载片以镊子转移至操作室台面上;开启氦气阀门,设定气流量和诱变时间进行诱变;诱变时间分别设定为90s、120s、150s、180s、210s;
(3)菌落计数:每次诱变结束后均将载片置于含990μL无菌生理盐水的EP管中,漩涡震荡1min;稀释涂布后置于30+2℃,50+5%相对湿度下培养5天,对长出的单菌落进行观察计数;
(4)菌株初筛:从各处理组分分别挑取20个单菌落进行斜面传代以及后续的摇瓶初筛;
(5)菌株复筛:从初筛结果中选出效价高的突变菌株,经反复多次复筛,选出前10%的突变菌株再进行复筛,复筛时一株作三个平行,对挑选出的典型诱变菌株,逐一进行发酵摇瓶考察,选择起步效价、放瓶单位和菌浓均较高的菌种,即为含有生产维生素B12的突变菌株。
本发明所述的诱变技术方案中涉及的筛选平板和传代斜面的培养基组成包括:甜菜糖蜜7.0-9.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌0.5%,磷酸氢二铵2.75%和琼脂1.2-1.5g/L,其余为水,除已经标注的外,各浓度均为重量百分比浓度;其pH值为7.0-7.5。
本发明涉及的菌株初筛中筛选种瓶用的培养基组成重量百分比包括:甜菜糖蜜5.0-7.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,5,6-二甲基苯并咪唑(DMBI)0.05%和磷酸氢二铵2.75%,其余的为水,其pH值为7.0-7.5。
本发明涉及的菌株复筛中的筛选摇瓶的培养基重量百分比组成包括:甜菜糖蜜8.0-11.0%,蔗糖1.8%,氯化胆碱1.5%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,5,6-二甲基苯并咪唑(DMBI)0.05%,尿素0.05%和磷酸氢二铵2.75%,其余为水,其pH7.0-7.5。
本发明所述的突变菌株TP-121实现工业发酵生产维生素B12的方法包括如下步骤:
(1)种瓶制备:将斜面菌用无菌水洗下后接入种瓶培养,30℃,200rpm,发酵2d,发酵结束后将种子液收集到3L的无菌瓶中,得到种子罐的种瓶;
(2)种子罐培养:将种瓶接种到种子罐中,30℃,180-300rpm,发酵48h;
(3)发酵罐培养:在无菌条件下,按照8%的接种量,将种子罐发酵液压入发酵罐,进行发酵罐培养;30℃,180-300rpm,发酵至60h后控制溶氧20%-30%,40h开始补料,发酵至菌体自溶严重,单位无明显提高时放罐;
其中,种子培养基质量百分比组成如下:糖蜜10%-12%,硫酸铵2.0%-2.5%,磷酸氢二铵0.5%-1.0%,硫酸锰0.1%-0.2%,硫酸镁1.2%-1.5%,硫酸锌0.5%-0.8%,其余为水,pH7.0-7.5;
发酵培养基质量百分百组成如下:糖蜜12%-15%,(NH4)2HPO40.5%-1%,硫酸铵1%-2%,氯化钴0.03%,5,6-二甲基苯并咪唑(DMBI)0.1%-0.15%,甜菜碱2%-3%,硫酸镁2.0%-3.0%,碳酸钙1.0-1.5%,其余为水,pH7.0-7.5;
补料培养基以糖蜜或葡萄糖作为补料碳源,其总糖浓度为150-200g/L。
本发明与现有技术相比,通过对原始菌株进行诱变后,再次通过常温常压等离子体(ARTP)诱变技术对一株具有典型诱变特征的菌株进行了诱变,最终获得遗传性质稳定、发酵水平较高的菌种,再经过培养基优化和发酵工艺条件优化,建立了液体发酵维生素B12的方法;所制备菌种的最适生长温度为30℃,生长所需的pH范围为7.0-7.5,发酵至144h左右达到最大菌浓,比原始菌株同时期菌浓提高了16.5%;与另两种菌株相比,对数期由原先的120h左右,缩短至96h左右,为后期产B12奠定了基础;该菌株最终发酵单位达到315ug/mL,明显高于原始菌株,大大降低了生产成本;其工艺原理可靠,操作步骤简单,技术条件成熟,菌种优质,维生素产量高,应用环境友好。
附图说明:
图1为本发明涉及的维生素B12的分子化学结构示意图。
图2为本发明涉及的不同菌株的发酵水平曲线示意图。
图3为本发明涉及的常温常压等离子体(ARTP)诱变致死曲线示意图。
图4为本发明涉及的发酵过程菌浓变化曲线示意图。
图5为本发明涉及的发酵过程中维生素B12单位变化曲线示意图。
具体实施方式:
以下通过具体实施例并结合附图对本发明做更详细的说明。
实施例1:
本施实例涉及一种突变菌株的诱变选育,其具体工艺步骤为:
(1)取两株出发菌株的新鲜斜面,用无菌水洗脱菌体,在有玻璃珠的试管振荡使菌体分散,离心收集菌体,以5%甘油重悬菌体,以血球计数板计数直至菌浓为107-108个/mL,以此作为出发菌悬液;
(2)开启常温常压等离子系统,以酒精棉擦拭操作室内外,并开启紫外灯灭菌30min;灭菌结束后取10μL菌悬液点于载片的粗糙面,并在无菌条件下将载片以镊子转移至操作室台面上;开启氦气阀门,设定气流量和诱变时间进行诱变;诱变时间分别设定为90s、120s、150s、180s、210s;
(3)每次诱变结束后均将载片置于含990μL无菌生理盐水的EP管中,漩涡震荡1min;稀释涂布后置于30+2℃,50+5%相对湿度下培养5天;对长出的单菌落进行观察计数;
(4)筛选平板和传代斜面的培养基组成如下:甜菜糖蜜7.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌0.5%,磷酸氢二铵2.75%,琼脂1.2-1.5g/L,其余为水,pH7.0-7.5;
其中,筛选种瓶的培养基组成如下:甜菜糖蜜7.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,DMBI0.05%,磷酸氢二铵2.75%,其余为水,pH7.0-7.5;
筛选摇瓶的培养基组成如下:甜菜糖蜜8.0%,蔗糖1.8%,氯化胆碱1.5%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,DMBI0.05%,尿素0.05%,磷酸氢二铵2.75%,其余为水,pH7.0-7.5;
菌株初筛:从各处理组分分别挑取20个单菌落进行斜面传代以及后续的摇瓶初筛;
菌株复筛:从初筛结果中选出效价高的突变株,经反复多次复筛,选出前10%的突变株再进行复筛,复筛时一株作三个平行,对挑选出的典型诱变菌株,逐一进行发酵摇瓶考察,选择起步效价、放瓶单位和菌浓均较高的菌种;复筛摇瓶发酵7天后放瓶,筛选出5株具有较高发酵单位的突变株,列表如下:
菌株 | 原始菌株 | TY-007 | TP-21 | TP-28 | TP-45 | TP-72 | TP-121 |
发酵单位(ug/mL) | 212 | 235 | 256 | 252 | 250 | 252 | 268 |
经再次的摇瓶发酵后选育出TP-121为稳定的最高酶活菌株形态特征观察:镜检该菌丝较短,菌形排列一致,着色较深,摇瓶后期菌丝拉长产生膨大端。
实施例2:
本施实例涉及一种利用突变菌株的液体发酵生产维生素B12的具体工艺:
(1)斜面培养:将所述TP-121取一接种环菌苔接种于斜面培养基中,30℃培养3d;
(2)种瓶培养:挖取斜面菌块接种于种瓶培养基中,30℃,200rpm,培养2d;
(3)种子罐培养:将种瓶发酵后的种子液合瓶按照接种量5%的比例接入种子罐,30℃,180-300rpm,发酵48h;
(4)发酵罐培养:将种子罐中的种子液按照接种量8%的比例接入发酵罐,30℃,180-300rpm,发酵至60h后控制溶氧20%-30%,40h开始补料,发酵至菌体自溶严重,单位无明显提高时放罐,发酵周期为200h-240h;下表是50L发酵罐6批次的发酵情况,平均发酵水平为311.88ug/mL;
批次 | 发酵周期(h) | 发酵活力(ug/mL) |
1 | 225 | 307.25 |
2 | 236 | 315.62 |
3 | 217 | 309.63 |
4 | 232 | 312.56 |
5 | 213 | 305.87 |
6 | 231 | 320.36 |
斜面培养基配制如下:甜菜糖蜜7.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌0.5%,磷酸氢二铵2.75%,琼脂1.2-1.5g/L,其余为水,pH7.0-7.5;
种子培养基质量体积百分比组成如下:糖蜜10%,硫酸铵2.0%,磷酸氢二铵1.0%,硫酸锰0.1%%,硫酸镁1.5%,硫酸锌0.8%,其余为水,pH7.0-7.5;
发酵培养基质量体积百分百组成如下:糖蜜15%,(NH4)2HPO40.5%,硫酸铵2%,氯化钴0.03%,DMBI0.1%,甜菜碱2%,硫酸镁2.0%,碳酸钙1.5%,其余为水,pH7.0-7.5;
补料培养基:以糖蜜或葡萄糖作为补料碳源,其总糖浓度均控制在150-200g/L。
实施例3:
本实施例涉及维生素B12含量的测定方法,采用高效液相色谱法,发酵液中的既存在于胞内又存在于胞外,在测定发酵液中的时需要将菌体破碎,具体的操作步骤如下:
(1)样品制备
取发酵液,加入亚硝酸钠溶液和冰醋酸各,摇匀,于95-100℃水浴水浴后冷却至室温,加去离子水定容至,过滤所得滤液用林微孔滤膜针头过滤器过滤至样品瓶中,用微量进样器吸取氰化钠溶液林放入样品瓶中,将样品瓶放入35-40℃水浴中反应1小时,使发酵液中不同形式的维生素转化为氰钻胺素,在给定条件下进行液相色谱分析;
(2)高效液相色谱条件
流动相为磷酸水溶液一乙睛,色谱柱为菲罗门,250mm×4.6mm,um;检测波长为361nm,进样量是20uL,流速为1.7mL/min;
色谱柱型号:C18;生产厂家:菲罗门;250mm×4.6mm;5um;
检测波长:260nm,流速:1mL/min;进样量:10uL,柱温40℃;
流动相:称取磷酸二氢钾(纯度99.5%)6.84g,置于1000mL容量瓶中,加纯化水溶解并稀释至刻度,用磷酸调节pH至3.2,摇匀,用0.45微米的微孔滤膜过滤得0.05mol/L的磷酸二氢钾溶液。将乙腈与0.05mol/L磷酸二氢钾溶液按150:850的比例混匀,放入超声水浴中脱气10min即可;
(3)线性及范围:
精密称取50mg至100mL棕色容量瓶中,加入纯化水溶解并稀释至刻度,混合均匀,得到标准贮备液500ug/mL。精密量取此标准贮备液5mL至50mL棕色容量瓶中,用纯化水稀释至刻度,混合均匀,作为标准品样液。
本实施例制备的菌株发酵后维生素B12的含量为320-350ug/mL,其提取收率为90%以上;所制备的维生素B12应用于医药、营养补充剂、饲料和食品加工等行业,可辅助治疗巨幼红细胞性贫血、药物中毒引起的贫血、再生障碍性贫血和白细胞减少症等;维生素B12还有维护神经髓鞘的代谢与功能,作为一些神经方面疾病或损伤的辅助治疗药物;在饲料行业中,维生素B12可以促进动物对蛋白质的利用和个体的生长,特别是幼小动物。
Claims (5)
1.一种高产维生素B12的突变菌株制备方法,其特征在于涉及的脱氮假单胞菌的具体诱变工艺步骤如下:
(1)出发菌悬液制备:取两株出发菌株的新鲜斜面,用无菌水洗脱菌体,在有玻璃珠的试管振荡使菌体分散,离心收集菌体,以5%甘油重悬菌体,以血球计数板计数直至菌浓为107-108个/mL,制得出发菌悬液;
(2)诱变:开启常温常压等离子出发系统,以酒精棉擦拭操作室内外空间,并开启紫外灯灭菌30min,灭菌结束后取10μL菌悬液点于载片的粗糙面,并在无菌条件下将载片以镊子转移至操作室台面上;开启氦气阀门,设定气流量和诱变时间进行诱变;诱变时间分别设定为90s、120s、150s、180s、210s;
(3)菌落计数:每次诱变结束后均将载片置于含990μL无菌生理盐水的EP管中,漩涡震荡1min;稀释涂布后置于30+2℃,50+5%相对湿度下培养5天,对长出的单菌落进行观察计数;
(4)菌株初筛:从各处理组分分别挑取20个单菌落进行斜面传代以及后续的摇瓶初筛;
(5)菌株复筛:从初筛结果中选出效价高的突变菌株,经反复多次复筛,选出前10%的突变菌株再进行复筛,复筛时一株作三个平行,对挑选出的典型诱变菌株,逐一进行发酵摇瓶考察,选择起步效价、放瓶单位和菌浓均较高的菌种,即为含有生产维生素B12的突变菌株。
2.根据权利要求1所述的高产维生素B12的突变菌株制备方法,其特征在于涉及的筛选平板和传代斜面的培养基组成包括:甜菜糖蜜7.0-9.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌0.5%,磷酸氢二铵2.75%和琼脂1.2-1.5g/L,其余为水,除已经标注的外,各浓度均为重量百分比浓度;其pH值为7.0-7.5。
3.根据权利要求1所述的高产维生素B12的突变菌株制备方法,其特征在于涉及的菌株初筛中筛选种瓶用的培养基组成重量百分比包括:甜菜糖蜜5.0-7.0%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,5,6-二甲基苯并咪唑(DMBI)0.05%和磷酸氢二铵2.75%,其余的为水,其pH值为7.0-7.5。
4.根据权利要求1所述的高产维生素B12的突变菌株制备方法,其特征在于涉及的菌株复筛中的筛选摇瓶的培养基重量百分比组成包括:甜菜糖蜜8.0-11.0%,蔗糖1.8%,氯化胆碱1.5%,硫酸铵0.45%,硫酸镁2.5%,硫酸锰0.2%,硫酸锌1.2%,氯化钴0.05%,5,6-二甲基苯并咪唑(DMBI)0.05%,尿素0.05%和磷酸氢二铵2.75%,其余为水,其pH7.0-7.5。
5.一种突变菌株TP-121实现工业发酵生产维生素B12的方法,其特征在于包括如下步骤:
(1)种瓶制备:将斜面菌用无菌水洗下后接入种瓶培养,30℃,200rpm,发酵2d,发酵结束后将种子液收集到3L的无菌瓶中,得到种子罐的种瓶;
(2)种子罐培养:将种瓶接种到种子罐中,30℃,180-300rpm,发酵48h;
(3)发酵罐培养:在无菌条件下,按照8%的接种量,将种子罐发酵液压入发酵罐,进行发酵罐培养;30℃,180-300rpm,发酵至60h后控制溶氧20%-30%,40h开始补料,发酵至菌体自溶严重,单位无明显提高时放罐;
其中,种子培养基质量百分比组成如下:糖蜜10%-12%,硫酸铵2.0%-2.5%,磷酸氢二铵0.5%-1.0%,硫酸锰0.1%-0.2%,硫酸镁1.2%-1.5%,硫酸锌0.5%-0.8%,其余为水,pH7.0-7.5;
发酵培养基质量百分百组成如下:糖蜜12%-15%,(NH4)2HPO40.5%-1%,硫酸铵1%-2%,氯化钴0.03%,5,6-二甲基苯并咪唑(DMBI)0.1%-0.15%,甜菜碱2%-3%,硫酸镁2.0%-3.0%,碳酸钙1.0-1.5%,其余为水,pH7.0-7.5;
补料培养基以糖蜜或葡萄糖作为补料碳源,其总糖浓度为150-200g/L。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811109813.9A CN109207469A (zh) | 2018-09-21 | 2018-09-21 | 一种高产维生素b12的突变菌株制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811109813.9A CN109207469A (zh) | 2018-09-21 | 2018-09-21 | 一种高产维生素b12的突变菌株制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109207469A true CN109207469A (zh) | 2019-01-15 |
Family
ID=64985163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811109813.9A Pending CN109207469A (zh) | 2018-09-21 | 2018-09-21 | 一种高产维生素b12的突变菌株制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109207469A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110408609A (zh) * | 2019-08-12 | 2019-11-05 | 山东泓达生物科技有限公司 | 一种高产β-法尼烯突变菌株的复合诱变育种方法 |
CN111254173A (zh) * | 2019-12-26 | 2020-06-09 | 湖北广济药业股份有限公司 | 一种脱氮假单胞菌发酵生产维生素b12高产菌株的筛选方法和筛选培养基 |
CN112694991A (zh) * | 2020-12-29 | 2021-04-23 | 河北华北制药华恒药业有限公司 | 一种产维生素b12的菌株及其应用 |
CN114231450A (zh) * | 2021-12-15 | 2022-03-25 | 黑龙江新和成生物科技有限公司 | 一种粘着箭菌及其制备方法和在生产维生素b12中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101748177A (zh) * | 2008-12-09 | 2010-06-23 | 华东理工大学 | 优化的脱氮假单胞菌发酵生产维生素b12方法与合成培养基 |
CN102453690A (zh) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | 一种脱氮假单胞菌发酵生产维生素b12高产菌株的诱变方法 |
CN102453740A (zh) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | 脱氮假单胞菌发酵生产维生素b12的培养基及发酵方法 |
-
2018
- 2018-09-21 CN CN201811109813.9A patent/CN109207469A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101748177A (zh) * | 2008-12-09 | 2010-06-23 | 华东理工大学 | 优化的脱氮假单胞菌发酵生产维生素b12方法与合成培养基 |
CN102453690A (zh) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | 一种脱氮假单胞菌发酵生产维生素b12高产菌株的诱变方法 |
CN102453740A (zh) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | 脱氮假单胞菌发酵生产维生素b12的培养基及发酵方法 |
Non-Patent Citations (1)
Title |
---|
蔡莹瀛等: "常压室温等离子体(ARTP)诱变及高通量筛选 维生素 B12高产菌株", 《天津科技大学学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110408609A (zh) * | 2019-08-12 | 2019-11-05 | 山东泓达生物科技有限公司 | 一种高产β-法尼烯突变菌株的复合诱变育种方法 |
CN111254173A (zh) * | 2019-12-26 | 2020-06-09 | 湖北广济药业股份有限公司 | 一种脱氮假单胞菌发酵生产维生素b12高产菌株的筛选方法和筛选培养基 |
CN112694991A (zh) * | 2020-12-29 | 2021-04-23 | 河北华北制药华恒药业有限公司 | 一种产维生素b12的菌株及其应用 |
CN112694991B (zh) * | 2020-12-29 | 2022-04-12 | 河北华北制药华恒药业有限公司 | 一种产维生素b12的菌株及其应用 |
CN114231450A (zh) * | 2021-12-15 | 2022-03-25 | 黑龙江新和成生物科技有限公司 | 一种粘着箭菌及其制备方法和在生产维生素b12中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109207469A (zh) | 一种高产维生素b12的突变菌株制备方法 | |
CN104561154B (zh) | 一种辅酶q10发酵工艺及控制策略 | |
CN103451128A (zh) | 一株解淀粉芽孢杆菌及其在防治桃流胶病中的应用 | |
CN112239728B (zh) | 一种适用于蛹虫草菌培养的含有还原型谷胱甘肽的合成培养基、制备方法及应用 | |
CN103146624A (zh) | 一种三株地衣芽孢杆菌混合液体发酵工艺 | |
CN112375755A (zh) | 一种高产β-葡萄糖苷酶的黑曲霉的选育方法 | |
CN101173221A (zh) | 小麦栽培北虫草的方法 | |
CN105695342B (zh) | 康氏木霉菌tg-72及其在黄曲霉菌生物防治中的应用 | |
CN104277989B (zh) | 一株面包酵母及其在发酵生产辅酶i中的应用 | |
CN101709297A (zh) | 一种花生四烯酸产生菌高山被孢霉的诱变筛选方法 | |
CN108294049B (zh) | 一种治疗柑橘黄龙病的多粘类芽孢杆菌培养液复合药物及其制备方法 | |
CN109182151A (zh) | 银杏内生真菌的分离筛选方法 | |
CN102816717B (zh) | 一株孔氏葡萄球菌及其制备5-氨基乙酰丙酸的方法 | |
CN107347446A (zh) | 北虫草的培养方法 | |
RU2409660C1 (ru) | Штамм бактерий bacillus mucilaginosus, обладающий антагонистической активностью по отношению к фитопатогенным микроорганизмам и способностью трансформировать труднодоступный для растений фосфор, и его применение | |
EP3483280B1 (en) | A fermentation method for producing gellan gum | |
CN114292774B (zh) | 一种菌丝体或菌体及其应用、及利用其选育菌株的方法 | |
CN101861796B (zh) | 一种利用有色稻米发酵废糟培养豹斑毒鹅膏的方法 | |
CN110172407A (zh) | 一株产果糖基转移酶的米曲霉及其应用 | |
CN103103134A (zh) | 一种蛇足石杉内生真菌及其产石杉碱甲的应用 | |
CN101760437B (zh) | 一种高核酸面包酵母及其制备方法 | |
CN107974413A (zh) | 赤霉酸种子液的制备方法 | |
CN114250176A (zh) | 一种微生物防治三七根腐病剂的制备方法及其应用 | |
CN102703332A (zh) | 一株产花生四烯酸油脂的菌株及其应用 | |
CN108085282B (zh) | 一种复合乳酸菌菌剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190115 |